These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38422524)

  • 41. Novel biosynthesized gold nanoparticles as anti-cancer agents against breast cancer: Synthesis, biological evaluation, molecular modelling studies.
    Vemuri SK; Banala RR; Mukherjee S; Uppula P; Gpv S; A V GR; T M
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():417-429. PubMed ID: 30889716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual-targeted delivery of paclitaxel and indocyanine green with aptamer-modified ferritin for synergetic chemo-phototherapy.
    Yang K; Dong Y; Li X; Wang F; Zhang Y
    Colloids Surf B Biointerfaces; 2023 Sep; 229():113437. PubMed ID: 37437411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Self-assembled polymeric nanoparticle of PEGylated chitosan-ceramide conjugate for systemic delivery of paclitaxel.
    Battogtokh G; Ko YT
    J Drug Target; 2014 Nov; 22(9):813-21. PubMed ID: 24964055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Folic Acid and Chitosan-Functionalized Gold Nanorods and Triangular Silver Nanoplates for the Delivery of Anticancer Agents.
    Lee YJ; Kim YJ; Park Y
    Int J Nanomedicine; 2022; 17():1881-1902. PubMed ID: 35518450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polydopamine-tailored paclitaxel-loaded polymeric microspheres with adhered NIR-controllable gold nanoparticles for chemo-phototherapy of pancreatic cancer.
    Banstola A; Pham TT; Jeong JH; Yook S
    Drug Deliv; 2019 Dec; 26(1):629-640. PubMed ID: 31237149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals.
    Sohn JS; Yoon DS; Sohn JY; Park JS; Choi JS
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():228-237. PubMed ID: 28024581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Internalization capabilities of gold-198 nanoparticles: Comparative evaluation of effects of chitosan agent on cellular uptake into MCF-7.
    Rovais MRA; Alirezapour B; Moassesi ME; Amiri M; Novin FB; Maadi E
    Appl Radiat Isot; 2018 Dec; 142():85-91. PubMed ID: 30273763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers.
    Kim SS; Kim HK; Kim H; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
    Arch Pharm Res; 2021 Feb; 44(2):182-193. PubMed ID: 32803685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticancer activity of gold nanobioconjugates synthesized from
    Shinde AS; Mendhulkar VD
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer.
    Tang B; Qian Y; Gou Y; Cheng G; Fang G
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30366367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chitosan functionalisation of gold nanoparticles encourages particle uptake and induces cytotoxicity and pro-inflammatory conditions in phagocytic cells, as well as enhancing particle interactions with serum components.
    Boyles MS; Kristl T; Andosch A; Zimmermann M; Tran N; Casals E; Himly M; Puntes V; Huber CG; Lütz-Meindl U; Duschl A
    J Nanobiotechnology; 2015 Nov; 13():84. PubMed ID: 26582370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmonic hyperthermia or radiofrequency electric field hyperthermia of cancerous cells through green-synthesized curcumin-coated gold nanoparticles.
    Rezaeian A; Amini SM; Najafabadi MRH; Farsangi ZJ; Samadian H
    Lasers Med Sci; 2022 Mar; 37(2):1333-1341. PubMed ID: 34406533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Curcumin and Paclitaxel Co-loaded Heparin and Poloxamer P403 Hybrid Nanocarrier for Improved Synergistic Efficacy in Breast Cancer.
    Nguyen NT; Bui QA; Huynh PD; Nguyen QH; Tran NQ; Viet NT; Nguyen DT
    Curr Drug Deliv; 2022 Aug; 19(9):966-979. PubMed ID: 35366771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymer decorated gold nanoparticles in nanomedicine conjugates.
    Capek I
    Adv Colloid Interface Sci; 2017 Nov; 249():386-399. PubMed ID: 28259207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
    Yang H; Tang C; Yin C
    Acta Biomater; 2018 Jun; 73():400-411. PubMed ID: 29660508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fabrication of poly(acrylic acid) grafted-chitosan/polyurethane/magnetic MIL-53 metal organic framework composite core-shell nanofibers for co-delivery of temozolomide and paclitaxel against glioblastoma cancer cells.
    Bazzazzadeh A; Dizaji BF; Kianinejad N; Nouri A; Irani M
    Int J Pharm; 2020 Sep; 587():119674. PubMed ID: 32707243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gold Nanoparticle-Decorated Drug Nanocrystals for Enhancing Anticancer Efficacy and Reversing Drug Resistance Through Chemo-/Photothermal Therapy.
    Wang J; Zhao H; Song W; Gu M; Liu Y; Liu B; Zhan H
    Mol Pharm; 2022 Jul; 19(7):2518-2534. PubMed ID: 35549267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surface charge-switchable polymeric magnetic nanoparticles for the controlled release of anticancer drug.
    Shen JM; Yin T; Tian XZ; Gao FY; Xu S
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):7014-24. PubMed ID: 23815399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.